Setting the efficacy of using melatonin in experimental diabetes mellitus 2 type


  • O. M. Oleshchuk
  • Ya. I. Ivankiv
Keywords: experimental diabetes, melatonin, prooxidant-antioxidant system, liver

Abstract

The effect of melatonin on indicators of prooxidant-antioxidant homeostasis, carbohydrate metabolism, liver condition and humoral immunity at the animals with experimental type 2 diabetes were studied. It was established that the usage of this agent at a dose of 10 mg / kg intraperitoneally during 10 days lead to inhibition of lipid peroxidation processes, activation of humoral and antioxidant protection of the organism, reduce levels of glucose and markers of liver damage.

Published
2017-03-31
How to Cite
Oleshchuk, O. M., & Ivankiv, Y. I. (2017). Setting the efficacy of using melatonin in experimental diabetes mellitus 2 type. Biomedical and Biosocial Anthropology, (25), 37-41. Retrieved from https://bba-journal.com/index.php/journal/article/view/71